| Mon, Nov 2, 2009 | | • | Qiao Xing Mobile Communications, Human Genome Sciences: Biggest Price Gainers (QXM, HGSI)
at The Wall Street Journal Online (Mon, Nov 2)
| | • | Will Technicals Destroy Market Rally?
at Investopedia (Mon, Nov 2)
| | • | Busting Out With Biotech And Emerging Markets
at Forbes.com (Mon, Nov 2)
| | • | Finally Convinced? Benlysta Works!
at Motley Fool (Mon, Nov 2)
| | • | Biotech Stocks: Human Genome rallies, GTX craters
at MarketWatch (Mon, Nov 2)
| | • | Making Money With Moving Averages
at Forbes.com (Mon, Nov 2)
| | • | Genomics: No Longer A Failure
at Forbes.com (Mon, Nov 2)
| | • | Biotech Stocks: Human Genome, Vertex, Amylin in play
at MarketWatch (Mon, Nov 2)
| | • | Indications: U.S. stock futures climb ahead of ISM report
at MarketWatch (Mon, Nov 2)
| | • | [video] Biopharma Barrage
at CNBC (Mon, Nov 2)
| | • | Futures Gain After Friday Drop; Ford Jumps
at CNBC (Mon, Nov 2)
| | • | Biotech Calendar: Key Dates for November
at TheStreet.com (Mon, Nov 2)
| | • | Human Genome Sciences and GlaxoSmithKline Announce Positive Results in Second of Two Phase 3 Trials of BENLYSTA in Systemic Lupus Erythematosus
Business Wire (Mon, Nov 2)
| | • | HUMAN GENOME SCIENCES INC Files SEC form 8-K, Results of Operations and Financial Condition
EDGAR Online (Mon, Nov 2)
| | • | Human Genome Calls Second Lupus Drug Study a Success
at TheStreet.com (Mon, Nov 2)
| | • | Human Genome, GSK see progress with lupus drug
at MarketWatch (Mon, Nov 2)
| | Fri, Oct 30, 2009 | | • | Earnings? Yawn. Trial Data? Moving!
at Motley Fool (Fri, Oct 30)
| | • | Human Genome Faces Binary Event
at Minyanville.com (Fri, Oct 30)
| | • | Biotech Mailbag: The Reason(s) for This Selloff
at TheStreet.com (Fri, Oct 30)
| | Thu, Oct 29, 2009 | | • | Earnings roundup: Callaway Golf, BMC Software
AP (Thu, Oct 29)
| | • | Human Genome Sciences books smaller 3Q loss
AP (Thu, Oct 29)
| | • | HUMAN GENOME SCIENCES INC Files SEC form 10-Q, Quarterly Report
EDGAR Online (Thu, Oct 29)
| | • | Human Genome Sciences Announces Third Quarter 2009 Financial Results and Key Developments
Business Wire (Thu, Oct 29)
| | • | Human Genome's Binary Bet
at Barrons.com (Thu, Oct 29)
| | • | Biotech Stocks: BioMarin, Human Genome lead drug stocks higher
at MarketWatch (Thu, Oct 29)
|
Add HGSI News to My Yahoo!:
 
| |
|
0.51% Nasdaq 
Headlines
